Ronald Simon
Impact in
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 189
- HER2/EGFR in Cancer Research 52
- Cancer-related Molecular Pathways 33
- Cancer Immunotherapy and Biomarkers 28
- Cancer Research 117
- Cancer Genomics and Diagnostics 78
- Co-authors
- Guido Sauter (251 shared papers)Martina Mirlacher (38 shared papers)Thorsten Schlomm (87 shared papers)Sarah Jane Pauline Minner (84 shared papers)Carsten Bokemeyer (34 shared papers)Hartwig Huland (48 shared papers)Markus Graefen (53 shared papers)Jakob Robert Izbicki (57 shared papers)
- Journals
- Human Pathology (18 papers)BMC Cancer (17 papers)Oncotarget (16 papers)Nature Communications (16 papers)Modern Pathology (15 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Ronald Simon
571 papers receiving 50.0k citations
Ronald Simon's Hit Papers
Peers
Comparison fields: 5 of 183
- Cancer Research 15.1k
- Oncology 12.3k
- Pulmonary and Respiratory Medicine 11.0k
- Molecular Biology 24.5k
- Pathology and Forensic Medicine 3.8k
Countries citing papers authored by Ronald Simon
This map shows the geographic impact of Ronald Simon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Simon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Simon more than expected).
Fields of papers citing papers by Ronald Simon
This network shows the impact of papers produced by Ronald Simon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Simon. The network helps show where Ronald Simon may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronald Simon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 587 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics Hit paper breakdown → | 2018 | 2602 |
| 2 | The Molecular Taxonomy of Primary Prostate Cancer Hit paper breakdown → | 2015 | 2435 |
| 3 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 4 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Hit paper breakdown → | 2018 | 2334 |
| 5 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 6 | Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer Hit paper breakdown → | 2018 | 1720 |
| 7 | Comprehensive Characterization of Cancer Driver Genes and Mutations Hit paper breakdown → | 2018 | 1714 |
| 8 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation Hit paper breakdown → | 2018 | 1617 |
| 9 | Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas Hit paper breakdown → | 2018 | 810 |
| 10 | Genomic and Functional Approaches to Understanding Cancer Aneuploidy Hit paper breakdown → | 2018 | 749 |
| 11 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 12 | Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients Hit paper breakdown → | 2018 | 685 |
| 13 | Pathogenic Germline Variants in 10,389 Adult Cancers Hit paper breakdown → | 2018 | 606 |
| 14 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines Hit paper breakdown → | 2018 | 583 |
| 15 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 569 |
| 16 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 17 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 18 | A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers Hit paper breakdown → | 2018 | 456 |
| 19 | Driver Fusions and Their Implications in the Development and Treatment of Human Cancers Hit paper breakdown → | 2018 | 451 |
| 20 | The Immune Landscape of Cancer Hit paper breakdown → | 2019 | 449 |
About Ronald Simon
Ronald Simon is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine, having authored 587 papers that have together received 50.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (99 papers), Cancer Genomics and Diagnostics (78 papers), HER2/EGFR in Cancer Research (52 papers), Genetic factors in colorectal cancer (41 papers), Bladder and Urothelial Cancer Treatments (39 papers), Cancer-related Molecular Pathways (33 papers), Cancer Immunotherapy and Biomarkers (28 papers) and Molecular Biology Techniques and Applications (27 papers). The work is most often cited by research in Cancer Research (15.1k citations), Oncology (12.3k citations), Pulmonary and Respiratory Medicine (11.0k citations), Molecular Biology (24.5k citations) and Pathology and Forensic Medicine (3.8k citations). Ronald Simon has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Guido Sauter, Martina Mirlacher, Thorsten Schlomm, Sarah Jane Pauline Minner, Carsten Bokemeyer, Hartwig Huland, Markus Graefen, Jakob Robert Izbicki, Luigi Maria TERRACCIANO and Peter Schraml. Their work appears in journals such as Human Pathology, BMC Cancer, Oncotarget, Nature Communications and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.